About 200 reports

Gene Therapy

  • Gene Therapy
  • Europe
  • Health Expenditure
  • Surgical Procedures Performed

Gene Therapy

  • Gene Therapy
  • World
  • Cancer Mortality
  • Cancer Incidence

Figure ##: Gene Therapy CDMOs by Number of Gene Therapy Facilities

  • Gene Therapy
  • World
  • Prescription Drug Sales
  • Drug Approval

Abstract: - Global Cancer Gene Therapy Market to Reach $3.8 Billion by 2027 - Amid the COVID-19 crisis, the global market for Cancer Gene Therapy estimated at US$611.9 Million in the year 2020, is projected to reach a revised size of US$3.8 Billion by 2027, growing at a CAGR of 29.6% over the analysis period 2020-2027....

  • Gene Therapy
  • World
  • China
  • United States

Abstract: - Global Hemophilia Gene Therapy Market to Reach $15.8 Billion by 2027 - Amid the COVID-19 crisis, the global market for Hemophilia Gene Therapy estimated at US$12.2 Billion in the year 2020, is projected to reach a revised size of US$15.8 Billion by 2027, growing at a CAGR of 3.8% over the analysis period...

  • Blood Disease
  • Gene Therapy
  • World
  • China
  • United States

## IN VIVO GENE THERAPY

  • Gene Therapy
  • United States
  • Europe
  • APAC
  • North America
  • Cancer Incidence
  • Drug Approval

Europe Gene Therapy Market

  • Gene Therapy
  • World
  • Dementia Prevalence
  • Schizophrenia Prevalence

The Global Gene Therapy Partnering Agreements 2010-2020 report provides an understanding and access to the gene therapy partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in gene therapy partnering deals Disclosed headlines, upfronts, milestones and royalties by stage...

  • Gene Therapy
  • World

‘Adeno-Associated Virus (AAV) Vector Based Gene Therapy- Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the AAV vector based gene therapy across the various therapeutic areas are several selected diseases, historical and forecasted AAV Vector Based Gene Therapy epidemiology in the 7MM, i.e., the United States,...

  • Gene Therapy
  • Germany
  • Spain
  • France
  • Italy
  • United Kingdom
  • Japan
  • United States
  • World

Gene Therapy Market Report Overview Gene Therapy market size outlook report provides comprehensive coverage of market landscape including strategic growth areas, unique insights, and major trends across Gene Therapy market types and applications. It is a focused study on Gene Therapy market space including global and regional eight-year...

  • Gene Therapy
  • World
  • Health Provider Density

Report Scope: The scope of this study encompasses an investigation of the markets cell and gene therapy tools such as GMP proteins, media, cell separation and activation reagents, viral and non-viral, cytokine release syndrome monitoring products, GMP antibodies, leukapheresis instrumentation, immunoassays (multiplex and...

  • In Vitro Diagnostics
  • Gene Therapy
  • Immunodiagnostics
  • World

INTRODUCTION Over time, several gene therapies have been developed for the treatment of both simple (single defect) and complex (multiple defects) genetic disorders. In fact, there are 10 approved gene therapies (recent examples include Zolgensma®, Zynteglo™ and Collategene®), till date, and more than a thousand product...

  • Gene Therapy
  • World
  • United States
  • Drug Approval

Gene Therapy Global Market Report 2020-30: COVID-19 Growth and Change provides the strategists, marketers and senior management with the critical information they need to assess the global gene therapy market market. This report focuses on gene therapy market market which is experiencing strong growth. The report gives a guide to the...

  • Gene Therapy
  • World

Major players in the cell and gene therapy market are Gilead Sciences, Bristol-Myers Squibb, Novartis AG, Amgen, Merck, Organogenesis Holdings, Dendreon, Vericel, Bluebird Bio and Fibrocell Science. The global cell and gene therapy market is expected to decline from $6.68 billion in 2019 to $6.92 billion in 2020 at a compound annual...

  • Gene Therapy
  • World
  • United States

"Global Gene Therapy Market Opportunity & Clinical Trials Insight 2026" Report Highlight: • Global Gene Therapy Market Opportunity: > US$ 8 Billion  • Global Gene Therapy Clinical Pipeline: > 1000 Therapies In Clinical Trials  • Commercially Available Gene Therapies: 11  • USA Dominates...

  • Gene Therapy
  • World

INTRODUCTION Since the approval of the first therapy, Genedicine® in 2003, the gene therapy domain has evolved significantly. Specifically, in 2019, three gene therapies, namely Zolgensma® (US), Zynteglo™ (Europe) and Beperminogene Perplasmid (Japan), have received approval / conditional approval, leading to a marked upward...

  • Gene Therapy
  • World
  • United States
  • Europe
  • Japan
  • APAC
  • China
  • South Korea
  • Australia
  • Drug Approval
  • Number Of Enterprises

Abstract: - In a Major Setback to the Healthcare System, Non-COVID-19 Care Delivery Bears the Brunt of the Pandemic. Gene Therapy Market Slumps by -13.6% - The global market for Gene Therapy is expected to decline by -13.6% in the year 2020 and thereafter recover and grow to reach US$3.3 billion by the year 2027,...

  • Gene Therapy
  • World
  • United States
  • Drug Approval

Gene therapy is one of the most widely researched fields in the healthcare industry. The high potential of gene therapy to cure various chronic diseases makes it a popular research area. Various researches are being performed across the globe to explore the potential of gene therapy for the treatment of incurable diseases,...

  • Gene Therapy
  • World
  • North America
  • United States

Gene therapy is a novel area of medicine that involves the insertion of functional genes into cells to replace faulty or missing genes in order to treat genetic diseases. This report reviews key developments from across the gene therapy sector, evaluating the industry's commercial successes and failures, regulatory issues across key global...

  • Gene Therapy
  • World
  • Drug Approval

Global Cell and Gene Therapy Market to Grow at a CAGR of 33.82% from 2021-2027 Market Report Coverage - Cell and Gene Therapy Market Segmentation • By Product Type: Yescarta, Provenge, Luxtura, Kymriah, Imlygic, Gintuit, MACI, Laviv, Gendicine, Oncorine, Neovasculgen, Strimvelis, Invossa,...

  • Gene Therapy
  • World
  • APAC
  • Drug Approval
  • Cancer Incidence

Gene Therapy Cell Culture Media Market by Media Type (Serum Containing Media, Serum Free Media, Stem Cell Media, Specialty Media, Chemically Defined Media, Lysogeny Broth, Custom Media, and Others), Viral Vectors Type (Retroviruses, Lentiviruses, Adenoviruses, Adeno Associated Virus, Herpes Simplex Virus, Poxvirus, Vaccinia Virus,...

  • Gene Therapy
  • World
  • APAC

Gene Therapy Market Size, Share & Trends Analysis Report By Indication (Acute Lymphoblastic Leukemia, Large B-cell Lymphoma), By Vector Type, By Region, And Segment Forecasts, 2020 - 2027 The global gene therapy market size is expected to reach USD 6.6 billion by 2027, at a CAGR of 16.6% over the forecast period....

  • Gene Therapy
  • World
  • North America
  • United States
  • Drug Approval

Global Cell and Gene Therapy Manufacturing QC Market to Reach $5.92 Billion by 2030 Market Report Coverage - Cell and Gene Therapy Manufacturing QC Market Segmentation • Product – Services and Products (Kits and Assays, Instruments, Reagents, and Software) • Process – Starting Material...

  • Gene Therapy
  • World
  • APAC
  • Drug Approval

Gene Therapy Market by Vector Type (Viral Vector and Non-viral Vector), Gene Type (Antigen, Cytokine, Tumor Suppressor, Suicide, Deficiency, Growth Factors, Receptors, and Others), and Application (Oncological Disorders, Rare Diseases, Cardiovascular Diseases, Neurological Disorders, Infectious Disease, and Other Diseases): Global...

  • Gene Therapy
  • World
  • APAC
  • Europe

Global Cell and Gene Therapy Drug Delivery Devices Market to Reach $375.13 Thousand by 2030 Market Report Coverage - Cell and Gene Therapy Drug Delivery Devices Market Segmentation • Product Type – Subretinal Injection Cannula, Extension Tube, Intravenous Catheter, Sterile Insulin Syringe...

  • Gene Therapy
  • Drug Delivery
  • World
  • Drug Approval

Table ##: Gene Therapy Landscape, Summary of Key Pipeline Gene Therapies for Hemophilia A

  • Gene Therapy
  • Blood Disease
  • Therapy
  • World
  • APAC
  • Stem Cell Transplantation
  • Life Expectancy

Global Cancer Gene Therapy Market 2021-2025 The analyst has been monitoring the cancer gene therapy market and it is poised to grow by $ 2.96 bn during 2021-2025 progressing at a CAGR of 20% during the forecast period. Our report on cancer gene therapy market provides a holistic analysis, market size and forecast, trends,...

  • Gene Therapy
  • World

Global Cell and Gene Therapy Market to Grow at a CAGR of 36.52% from 2019-2025 Key Questions Answered in this Report: • What are the major market drivers, challenges, and opportunities in the global cell and gene therapy market? • What are the underlying structures resulting in the emerging trends...

  • Gene Therapy
  • World
  • Drug Approval

About this market The increase in special drug designations is one of the key factors anticipated to witness continuous growth in the forthcoming years. Vendors are receiving special drug designations for their novel gene therapies to help in receiving quicker approval. Some market players are even offering the orphan drug...

  • Gene Therapy
  • Mental Health
  • World

Gene Therapy

  • Gene Therapy
  • APAC
  • Europe
  • World
  • North America
  • Number Of Enterprises